Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines

KH Gibson, W Grundy, AA Godfrey…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 21 p. 2723 - 2728

Full Text: HTML

Citation Number: 77

Abstract

... Please enable JavaScript to use all the features on this page. Bioorganic & Medicinal Chemistry Letters. Volume 7, Issue 21, 4 November 1997, Pages 2723–2728. ... For a recent review and additional references see: Annual Reports in Medicinal Chemistry, Vol. ...

Related Articles:

Selective alkylation of a 6, 7-dihydroxyquinazoline

[Tetrahedron Letters, , vol. 46, # 45 p. 7715 - 7719]

Selective alkylation of a 6, 7-dihydroxyquinazoline

[Harris, Craig S.; Hennequin, Laurent F.; Kettle, Jason G.; Willerval, Olivier A. Tetrahedron Letters, 2005 , vol. 46, # 45 p. 7715 - 7719]

Studies leading to the identification of ZD1839 (Iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment …

[Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 14 p. 1911 - 1914]

Synthesis and evaluation of novel F-18 labeled 4-aminoquinazoline derivatives: Potential PET imaging agents for tumor detection

[Bioorganic and Medicinal Chemistry Letters, , vol. 22, # 14 p. 4745 - 4749]

Synthesis and evaluation of novel F-18 labeled 4-aminoquinazoline derivatives: Potential PET imaging agents for tumor detection

[Bioorganic and Medicinal Chemistry Letters, , vol. 22, # 14 p. 4745 - 4749]

More Articles...